Engineered hepatitis B virus surface antigen L protein particles for in vivo active targeting of splenic dendritic cells

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 3341-3350

  Matsuo, Hidenori ^a   Yoshimoto, Nobuo ^a   Iijima, Masumi ^a   Niimi, Tomoaki ^a   Jung, Joohee ^b,c   Jeong, Seong Yun ^c   Choi, Eun Kyung ^c,d   Sewaki, Tomomitsu ^e   Arakawa, Takeshi ^f,g   Kuroda, Shun'ichi ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b Duksung Women's University   (South Korea)

^c Asan Medical Center   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

^e Genolac BL Corporation   (Japan)

^f Department of Tropical Infectious Diseases   (Japan)

^g UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Drug delivery system; Gene delivery system; Liposomes; Protein A; Vaccine; ZZ domain

Indexed keywords

ALPHA CD11C ANTIBODY IMMUNOGLOBULIN G ANTIBODY IMMUNOGLOBULIN FC INTERACTING REGION BIONANOCAPSULE; ALPHA CD11C ANTIBODY IMMUNOGLOBULIN G2A ANTIBODY IMMUNOGLOBULIN FC INTERACTING REGION BIONANOCAPSULE; ALPHA MAJOR HISTOCOMPATIBILITY COMPLEX II IMMUNOGLOBULIN G2B ANTIBODY IMMUNOGLOBULIN FC INTERACTING REGION BIONANOCAPSULE; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN FC INTERACTING REGION BIONANOCAPSULE; NANOCAPSULE; NANOCARRIER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIGEN BINDING; ARTICLE; BIOACCUMULATION; CHEMICAL MODIFICATION; COMPLEX FORMATION; CONTROLLED STUDY; DENDRITIC CELL; EX VIVO STUDY; FEMALE; IMMUNOCYTOCHEMISTRY; IN VIVO STUDY; MOLECULAR CLONING; MOUSE; NANOENGINEERING; NONHUMAN; SPLEEN CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, VIRAL; BACTERIAL VACCINES; DENDRITIC CELLS; ENCEPHALITIS VIRUS, JAPANESE; FEMALE; HEPATITIS B SURFACE ANTIGENS; LIPOSOMES; MICE; MICE, INBRED BALB C; NANOCAPSULES; RECOMBINANT FUSION PROTEINS; SPLEEN; STAPHYLOCOCCAL PROTEIN A; TISSUE DISTRIBUTION; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

HEPATITIS B VIRUS; STAPHYLOCOCCUS AUREUS;

EID: 84870364967     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S32813     Document Type: Article

References (38)

1. Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol. 2005;23:975-1028.
2. Banchereau J, Briere F, Caux C, etal. Immunobiology of dendritic cells. Immunology. 2000;18:767-811.
3. Villadangos JA, Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol. 2007;7:543-555.
4. Albert ML, Pearce SF, Francisco LM, etal. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med. 1998;188:1359-1368.
5. Inaba K, Steinman RM. Accessory cell-T lymphocyte interactions, antigen-dependent and-independent clustering. J Exp Med. 1986;163:247-261.
6. Flatz L, Hegazy AN, Bergthaler A, etal. Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity. Nat Med. 2010;16:339-345.
7. Sevilla N, Kunz S, Holz A, etal. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J Exp Med. 2000;192:1249-1260.
8. Cervantes-Barragan L, Züst R, Maier R. Dendritic cell-specific antigen delivery by coronavirus vaccine vectors induces long-lasting protective antiviral and antitumor immunity. M Bio. 2010;1:e00171-10.
9. Yang L, Yang H, Rideout K, etal. Engineered lentivector targeting of dendritic cells for in vivo immunization. Nat Biotechnol. 2008;26:326-334.
10. Uto T, Wang X, Sato K, etal. Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity. J Immunol. 2007;178:2979-2986.
11. Dane KY, Nembrini C, Tomei AA, etal. Nano-sized drug-loaded micelles deliver payload to lymph node immune cells and prolong allograft survival. J Control Release. 2011;156(2):154-160.
12. van Broekhoven CL, Parish CR, Demangel C, Britton WJ, Altin JG. Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy. Cancer Res. 2004;64:4357-4365.
13. Wei H, Wang S, Zhang D, etal. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice. Clinical Cancer Res. 2009;15:4612-4621.
14. Faham A, Altin JG. Antigen-containing liposomes engrafted with flagellin-related peptides are effective vaccines that can induce potent antitumor immunity and immunotherapeutic effect. J Immunol. 2010;185:1744-1754.
15. White KL, Rades T, Furneaux RH, Tyler PC, Hook S. Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells. J Pharm Pharmacol. 2006;58:729-737.
16. Yamada T, Iwabuki H, Kanno T, etal. Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) protein. Vaccine. 2001;19:3154-3163.
17. Kuroda S, Otaka S, Miyazaki T, Nakao M, Fujisawa Y. Hepatitis B virus envelope L protein particles. Synthesis and assembly in Saccharomyces cerevisiae, purification and characterization. J Biol Chem. 1992;267:1953-1961.
18. Jung J, Iijima M, Yoshimoto N, etal. Efficient and rapid purification of drug-and gene-carrying bio-nanocapsules, hepatitis B virus surface antigen L particles, from Saccharomyces cerevisiae. Protein Expr Purif. 2011;78:149-155.
19. Yamada M, Oeda A, Jung J, etal. Hepatitis B virus envelope L protein-derived bio-nanocapsules: Mechanisms of cellular attachment and entry into human hepatic cells. J Control Release. 2012 10;160(2):322-9.
20. Yamada T, Iwasaki Y, Tada H, etal. Nanoparticles for the delivery of genes and drugs to human hepatocytes. Nat Biotechnol. 2003;21:885-890.
21. Jung J, Matsuzaki T, Tatematsu K, Okajima T, Tanizawa K, Kuroda S. Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials. J Control Release. 2008;126:255-264.
22. Nilsson B, Moks T, Jansson B, etal. A synthetic IgG-binding domain based on staphylococcal protein A. Protein Eng. 1987;1:107-113.
23. Kurata N, Shishido T, Muraoka M, etal. Specific protein delivery to target cells by antibody-displaying bionanocapsules. J Biochem. 2008;144:701-707.
24. Iijima M, Kadoya H, Hatahira S, etal. Nanocapsules incorporating IgG Fc-binding domain derived from Staphylococcus aureus protein A for displaying IgGs on immunosensor chips. Biomaterials. 2011;32:1455-1464.
25. Tsutsui Y, Tomizawa K, Nagita M, etal. Development of bionanocapsules targeting brain tumors. J Control Release. 2007;122:159-164.
26. Iijima M, Matsuzaki T, Kadoya H, etal. Bionanocapsule-based enzyme-antibody conjugates for enzyme-linked immunosorbent assay. Anal Biochem. 2010;396:257-261.
27. Iijima M, Matsuzaki T, Yoshimoto N, Niimi T, Tanizawa K, Kuroda S. Fluorophore-labeled nanocapsules displaying IgG Fc-binding domains for the simultaneous detection of multiple antigens. Biomaterials. 2011;32:9011-9020.
28. Kikuchi A, Aoki Y, Sugaya S. Development of novel cationic liposomes for efficient gene transfer into peritoneal disseminated tumor. Hum Gene Ther. 1999;10:947-955.
29. Tafuku S, Miyata T, Tadano M, etal. Japanese encephalitis virus structural and nonstructural proteins expressed in Escherichia coli induce protective immunity in mice. Microbes Infect. 2011:4-11.
30. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001;53:283-318.
31. de Jong JMH, Schuurhuis D, Ioan-Facsinay A, etal. Murine Fc receptors for IgG are redundant in facilitating presentation of immune complex derived antigen to CD8+ T cells in vivo. Mol Immunol. 2006;43:2045-2050.
32. Fournier B, Philpott DJ. Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev. 2005;18:521-540.
33. Ding X, Yang W, Shi X, etal. TNF receptor 1mediates dendritic cell maturation and CD8 T cell response through two distinct mechanisms. J Immunol. 2011;187:1184-1191.
34. Burgdorf S, Lukacs-Kornek V, Kurts C. The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation. J Immunol. 2006;176:6770-6776.
35. Pillarisetty VG, Shah AB, Miller G, Bleier JI, DeMatteo RP. Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition. J Immunol. 2004;172:1009-1017.
36. Klibanov AL, Maruyama K, Beckerleg AM, Torchilin VP, Huang L. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim Biophys Acta. 1991;1062:142-148.
37. Keizer GD, Te Velde AA, Schwarting R, Figdor CG, De Vries JE. Role of p150,95in adhesion, migration, chemotaxis and phagocytosis of human monocytes. Eur J Immunol. 1987;17:1317-1322.
38. Castro FVV, Tutt AL, White AL, etal. CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses. Eur J Immunol. 2008;38:2263-2273.